SC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial Cancers
Public ClinicalTrials.gov record NCT03138408. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Phase 1 Study of SC-004 as Monotherapy and in Combination With ABBV-181 in Subjects With Epithelial Ovarian, Including Fallopian Tube and Primary Peritoneal and Endometrial Cancers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a two-part study consisting of Part A (dose regimen finding) followed by Part B (dose expansion). Part A (dose regimen finding) will allow definition of the maximum tolerated dose (MTD) through dose escalation and possible dose interval modification. In Part B (dose expansion), potential therapeutic doses may be studied with SC-004 as monotherapy and SC-004 in combination with ABBV-181 in disease-specific cohorts.
Study identification
- NCT ID
- NCT03138408
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 24 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 13, 2017
- Primary completion
- May 1, 2019
- Completion
- May 1, 2019
- Last update posted
- May 13, 2019
2017 – 2019
United States locations
- U.S. sites
- 12
- U.S. states
- 12
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama /ID# 202249 | Birmingham | Alabama | 35294 | — |
| Highlands Oncology Group /ID# 209165 | Fayetteville | Arkansas | 72703-4005 | — |
| City of Hope /ID# 202493 | Duarte | California | 91010 | — |
| University of Chicago /ID# 200735 | Chicago | Illinois | 60637 | — |
| Henry Ford Health System /ID# 202480 | Detroit | Michigan | 48202 | — |
| Mayo Clinic - Rochester /ID# 200732 | Rochester | Minnesota | 55905-0001 | — |
| Washington University School /ID# 164091 | St Louis | Missouri | 63108 | — |
| The Ohio State University - Columbus /ID# 164089 | Columbus | Ohio | 43210 | — |
| Univ Oklahoma HSC /ID# 164090 | Oklahoma City | Oklahoma | 73104 | — |
| Tennessee Oncology-Nashville Centennial /ID# 164088 | Nashville | Tennessee | 37203-1632 | — |
| MD Anderson Cancer Center /ID# 200048 | Houston | Texas | 77030 | — |
| Huntsman Cancer Institute /ID# 209164 | Salt Lake City | Utah | 84112-5500 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cancer trials
Other public records listing Cancer. Sorted by last update posted; newest first. Not a recommendation.
- NCT07796347: Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias and Their Caregivers Not yet recruiting
- NCT07788339: Keep Social Randomized Controlled Trial for Young Adults With Cancer Not yet recruiting
- NCT07787806: A Randomized Controlled Trial to Compare the Effectiveness of a Patient-reported Outcomes-driven Supportive Care Navigation Among Hispanic/Latinx Cancer Patients Not yet recruiting
- NCT07780903: A Study of a Digital Program for Helping Young Adult Cancer Survivors Learn About Financial Issues Related to Healthcare Recruiting
- NCT07776964: Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE) Not yet recruiting
- NCT07776704: Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology Patients Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03138408, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2019 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03138408 live on ClinicalTrials.gov.